Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2011
06/15/2011CN101371844B Sticking tablet for curing mouth ulcer using mometasone furoate as active component
06/15/2011CN101366935B Externally used ultramicro powder traditional Chinese medicine preparation for treating soft tissue injury and preparation method thereof
06/15/2011CN101357919B Penem derivative containing sulfhydryl formamide benzenesulfonyl pyrrolidine
06/15/2011CN101353362B Extraction method of cyaniding 3-0-glucoside
06/15/2011CN101322791B Chinese medicine for treating chronic anemia
06/15/2011CN101288723B Combined type heating Chinese medicine pillow for treating cervical vertebra
06/15/2011CN101284022B Complexation extraction method of plant polyphenols substances
06/15/2011CN101279956B Matrix metalloprotease inhibitors and synthetic method thereof
06/15/2011CN101260077B Quinolin-2-ones derivative, pharmaceutical composition and use thereof
06/15/2011CN101253171B Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives
06/15/2011CN101249130B Medicinal or health care combination for stop smoking or alleviating stop smoking syndrome
06/15/2011CN101230067B Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors
06/15/2011CN101224194B Silybin guest nanometer particle and preparing method thereof
06/15/2011CN101218246B Improved crystalline form of compound A-348441
06/15/2011CN101204418B Application of Cajanus cajan L. extracts on preparating hyperlipemia medicine
06/15/2011CN101203219B Anti-inflammatory modalities
06/15/2011CN101186606B Ampelopsin derivative, synthesizing method thereof and application of the same in preparing antineoplastic medicine
06/15/2011CN101181623B Method for preparing alcohol extraction of white vein ointment
06/15/2011CN101177385B Aryl sulfonic acid amides and analogues as well as its purpose in curing neural degeneration disease
06/15/2011CN101176788B Pharmaceutical composition for ACE restrainer/uretica/folic acid, and uses thereof
06/15/2011CN101166528B Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (PEG2)
06/15/2011CN101163488B Composition anti-inflammatoire de l'intestin comprenant des maltodextrines branchees
06/15/2011CN101163455B Non-irritating compositions containing zinc salts
06/15/2011CN101155589B Composition for reducing the exudation of serum proteins
06/15/2011CN101151259B Heteroaryl urea derivatives useful for inhibiting CHKI
06/15/2011CN101137660B Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds
06/15/2011CN101137383B 增强型比马前列素眼用溶液 Enhanced bimatoprost ophthalmic solution
06/15/2011CN101130515B Substituted-1H- indoles compound, method for preparing the same, application and pharmaceutical composition of the same
06/15/2011CN101128194B Preventive antistress agent
06/15/2011CN101124228B Pyrazolopyrimidine compounds as antitumor agents
06/15/2011CN101119718B Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
06/15/2011CN101111495B Crystalline 1h-imidazo[4,5-b]pyridin-5-amine, 7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its pharmaceutical uses
06/15/2011CN101108835B Method of manufacturing high purity hydrochloric acid sarafloxacin
06/15/2011CN101094847B Aryloxy-substituted benzimidazole derivatives
06/15/2011CN101080381B Manufacture process of n-substituted salicylamides
06/15/2011CN101074252B 11,20-cyclic carbonate-azithromycin 4-phenproester derivative, its production and medicinal composition
06/15/2011CN101074251B Azithromycin 4-phenproester derivative, its production and medicinal composition
06/15/2011CN101072778B Novel pyrrolo [3, 2-d] pyrimidin-4-one derivatives and their use in therapy
06/15/2011CN101065118B A composition comprising at least 3 different diols
06/15/2011CN101056855B Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
06/15/2011CN101048156B Inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
06/15/2011CN101044120B Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
06/15/2011CN101039678B Imidazo[1,5a]triazolo[1,5d]benzodiazepine derivatives for the treatment of cognitive disorders
06/15/2011CN101035759B Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
06/15/2011CN101032489B Cefprozil dispersible table and the preparing method
06/15/2011CA2709095A1 Compositions and methods for controlling blood glucose levels
06/14/2011USRE42462 Carboxylic acid derivatives, their preparation and use
06/14/2011USRE42461 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
06/14/2011US7960588 Benzyl cycloalkyl sphingosine 1-phosphate receptor modulators
06/14/2011US7960579 2-amino-bicyclo [3.1.0] hexane-2,6-dicarboxylic ester derivative
06/14/2011US7960570 Small molecule inhibitors of rotamase enzyme activity
06/14/2011US7960569 Indole antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
06/14/2011US7960568 Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders
06/14/2011US7960567 Compounds and methods useful for treating asthma and allergic inflammation
06/14/2011US7960563 Indazoles used to treat estrogen receptor beta mediated disorders
06/14/2011US7960562 Propane-1,3-dione derivative or salt thereof
06/14/2011US7960561 2-(phenylamino) benzimidazole derivatives and their use as modulators of small-conductance calcium-activated potassium channels
06/14/2011US7960560 1-(biphenyl-4-ylmethyl)imidazolidine-2,4-dione
06/14/2011US7960556 Thiadiazole derivatives for the treatment of neuro-degenerative diseases
06/14/2011US7960549 Solid forms of a chemokine receptor antagonist and methods of use thereof
06/14/2011US7960527 Nucleic acid and corresponding protein entitled 151P3D4 useful in treatment and detection of cancer
06/14/2011US7960525 Gene repair involving in vivo excision of targeting DNA
06/14/2011US7960522 Certain aminoalkyl glucosaminide phosphate compounds and their use
06/14/2011US7960438 Use of agomelatine in obtaining medicaments intended for the treatment of generalized anxiety disorder
06/14/2011US7960437 Improving aesthetic appearance of skin by reducing wrinkles and fine lines, improving smoothness, texture, firmness, moisture, elasticity and resilience; topical application of a mixture of a phtyol and a cyclic-AMP derivative
06/14/2011US7960436 Therapy and prophylaxis of diseases and disorders such as seizure disorders; [1-Amino-5-(4-trifluoromethyl-phenylamino)-5,6,7,8-tetrahydro-naphthalen-2-yl]-carbamic acid ethyl ester
06/14/2011US7960435 Anti-cancer agents and androgen inhibition activity compound
06/14/2011US7960434 Small molecule inhibitors of STAT3 with anti-tumor activity
06/14/2011US7960433 Treatment of chemokine mediated diseases
06/14/2011US7960432 Compositions and products containing S-equol, and methods for their making
06/14/2011US7960430 Flavonoid complexes with cyclodextrins
06/14/2011US7960429 especially N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl)ethyl]-2,2-diphenylacetamide (Asimadoline) or salt; reduces symptoms of abnormal stool frequency, abnormal stool form, defecation straining, urgency, a feeling of incomplete bowel movement, passing mucus, and bloating
06/14/2011US7960428 (2-carbamoyl-5-chloro-1H-indol-3-yl)-[3-((E)-2-cyano-vinyl)-5-methyl-phenyl]-(S)-phosphinic acid methyl ester; Flaviviruses; bioavailability; pharmacokinetics
06/14/2011US7960427 Antivirals against Hepatitis B, HIV, and influenza viruses; e.g. ethyl 2-[(benzo[d]imidazol-2-yl)thiomethyl]-6-bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-1H-indole-3-carboxylate
06/14/2011US7960426 Substituted arylpyrazoles
06/14/2011US7960425 Pyrazole compounds and thrombopoietin receptor activators
06/14/2011US7960424 Liquid pharmaceutical formulations of palonosetron
06/14/2011US7960423 Imidazole-2-thiones
06/14/2011US7960422 Pharmaceutically active compounds containing tetrazolyl and triazolyl rings
06/14/2011US7960419 Substituted carboxamides
06/14/2011US7960417 Such as 1-(2,2-dimethylpropyl)-4-propyl-5-{4-[4-(1H-tetrazol-5-yl)phenoxy]butoxy}-1H-indole; neurological and psychiatric disorders
06/14/2011US7960416 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization
06/14/2011US7960415 Caspase inhibitors and uses thereof
06/14/2011US7960413 Pyrazole compounds
06/14/2011US7960412 Selective estrogen receptor modulator
06/14/2011US7960411 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
06/14/2011US7960410 Method for treating insulin resistance, abdominal obesity, hypertension, hyperinsulinemia, and elevated blood lipids with a cortisol inhibitor
06/14/2011US7960409 e.g. 4-(3-fluorophenyl)-7-({4-[1-hydroxy-1-(trifluoromethyl)propyl]-1H-1,2,3-triazol-1-yl}methyl)-2H-chromen-2-one; leukotriene biosynthesis and 5-lipoxygenase (5-LO); inhibitor; antiatherosclerotic, antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents
06/14/2011US7960408 Quinolinyl and benzothiazolyl modulators
06/14/2011US7960407 Crystal forms of an imidazole derivative
06/14/2011US7960406 Diketo substituted pyrrolo[2,3-c] pyridines
06/14/2011US7960405 Prodrug of Rapamycin analog; chemokine receptor antagonist; antiproliferative, antiinflammatory , anticarcinogenic agent, anticoagulant; autoimmune diseases; restenosis; stents, catheters, by-pass graft; drug delivery; balloon overcoated with drugs
06/14/2011US7960404 Spirocyclic cyclohexane compounds
06/14/2011US7960403 Such as (3S,4S)-3-[3-(4-Methanesulfonylbenzyl)-bicyclo[3.2.1]-2,4-dioxo-1 alpha ,3,8-triaza-spiro[4.5]dodec-8-ylmethyl]-4-phenyl-pyrrolidine-1-carboxylic acid tert-butyl ester; inflammation; HIV
06/14/2011US7960402 Carbamoyl-substituted spiro derivative
06/14/2011US7960401 Spiropiperidine derivatives for controlling pests
06/14/2011US7960400 Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof
06/14/2011US7960399 Quinazolinone derivatives useful as vanilloid antagonists
06/14/2011US7960398 Potent inhibitors of TNF activity
06/14/2011US7960397 6,9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions